Bank of Montreal’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.53M | Buy |
564,966
+527,531
| +1,409% | +$9.21M | ﹤0.01% | 1210 |
|
|
2026
Q1 | $718K | Buy |
37,435
+18,913
| +102% | +$411K | ﹤0.01% | 2212 |
|
|
2025
Q4 | $407K | Sell |
18,522
-16,271
| -47% | -$294K | ﹤0.01% | 2415 |
|
|
2025
Q3 | $422K | Sell |
34,793
-175,539
| -83% | -$2.38M | ﹤0.01% | 2341 |
|
|
2025
Q2 | $3.92M | Buy |
210,332
+198,942
| +1,747% | +$3.94M | ﹤0.01% | 1347 |
|
|
2025
Q1 | $218K | Buy |
11,390
+1,386
| +14% | +$40.6K | ﹤0.01% | 2690 |
|
|
2024
Q4 | $360K | Buy |
10,004
+409
| +4% | +$13.8K | ﹤0.01% | 2438 |
|
|
2024
Q3 | $407K | Sell |
9,595
-10,395
| -52% | -$441K | ﹤0.01% | 2546 |
|
|
2024
Q2 | $837K | Buy |
19,990
+11,045
| +123% | +$461K | ﹤0.01% | 2128 |
|
|
2024
Q1 | $319K | Buy |
8,945
+677
| +8% | +$18.1K | ﹤0.01% | 2738 |
|
|
2023
Q4 | $255K | Buy |
+8,268
| New | +$172K | ﹤0.01% | 2969 |
|
|
2023
Q2 | – | Sell |
-12,664
| Closed | -$516K | – | 4289 |
|
|
2023
Q1 | $516K | Sell |
12,664
-1,955
| -13% | -$80.9K | ﹤0.01% | 2439 |
|
|
2022
Q4 | $657K | Sell |
14,619
-2,223
| -13% | -$101K | ﹤0.01% | 2444 |
|
|
2022
Q3 | $839 | Sell |
16,842
-6,226
| -27% | -$341K | ﹤0.01% | 2282 |
|
|
2022
Q2 | $1.46K | Sell |
23,068
-79,361
| -77% | -$6.52M | ﹤0.01% | 2073 |
|
|
2022
Q1 | $12M | Buy |
102,429
+78,601
| +330% | +$9.18M | 0.01% | 1065 |
|
|
2021
Q4 | $3.65M | Sell |
23,828
-98
| -0.4% | -$13.2K | ﹤0.01% | 1343 |
|
|
2021
Q3 | $2.89M | Buy |
23,926
+4,758
| +25% | +$524K | ﹤0.01% | 1895 |
|
|
2021
Q2 | $1.92M | Buy |
19,168
+256
| +1% | +$22.8K | ﹤0.01% | 2085 |
|
|
2021
Q1 | $1.66M | Sell |
18,912
-19,496
| -51% | -$1.81M | ﹤0.01% | 1879 |
|
|
2020
Q4 | $3.67M | Sell |
38,408
-18,899
| -33% | -$1.95M | ﹤0.01% | 1547 |
|
|
2020
Q3 | $6.42M | Sell |
57,307
-9,857
| -15% | -$1.04M | 0.01% | 1067 |
|
|
2020
Q2 | $6.99M | Sell |
67,164
-1,130
| -2% | -$90.2K | 0.01% | 1023 |
|
|
2020
Q1 | $4.39M | Sell |
68,294
-14,236
| -17% | -$997K | 0.01% | 1041 |
|
|
2019
Q4 | $4.92M | Buy |
82,530
+9,459
| +13% | +$583K | ﹤0.01% | 1367 |
|
|
2019
Q3 | $4.31M | Buy |
73,071
+41,330
| +130% | +$2.64M | ﹤0.01% | 1280 |
|
|
2019
Q2 | $2.05M | Buy |
31,741
+31,445
| +10,623% | +$2.03M | ﹤0.01% | 1676 |
|
|
2019
Q1 | $19K | Sell |
296
-1,440
| -83% | -$75.6K | ﹤0.01% | 3692 |
|
|
2018
Q4 | $66K | Sell |
1,736
-469
| -21% | -$16.6K | ﹤0.01% | 3167 |
|
|
2018
Q3 | $94K | Buy |
2,205
+1,888
| +596% | +$65.9K | ﹤0.01% | 3126 |
|
|
2018
Q2 | $7K | Buy |
+317
| New | +$3.9K | ﹤0.01% | 4061 |
|
|
2016
Q2 | – | Sell |
-5
| Closed | – | – | 4318 |
|
|
2016
Q1 | $0 | Sell |
5
-1,340
| -100% | -$117K | ﹤0.01% | 4390 |
|
|
2015
Q4 | $160K | Sell |
1,345
-4,160
| -76% | -$413K | ﹤0.01% | 2547 |
|
|
2015
Q3 | $485K | Sell |
5,505
-1,500
| -21% | -$175K | ﹤0.01% | 1867 |
|
|
2015
Q2 | $760K | Hold |
7,005
| – | – | ﹤0.01% | 1783 |
|
|
2015
Q1 | $884K | Buy |
7,005
+7,000
| +140,000% | +$910K | ﹤0.01% | 1691 |
|
|
2014
Q4 | $1K | Buy |
+5
| New | +$693 | ﹤0.01% | 3930 |
|
|
2014
Q3 | – | Sell |
-23
| Closed | -$4K | – | 4395 |
|
|
2014
Q2 | $4K | Buy |
+23
| New | +$3.91K | ﹤0.01% | 4281 |
|
Other funds holding TNDM
FLAM
GKIM
PIM
FGP
Bank of Montreal's TNDM Position: Q2 2026 in Review
Bank of Montreal increased its Tandem Diabetes Care (TNDM) stake by 1,409% in Q2 2026, buying an estimated $9.21M and bringing the position to 564,966 shares worth $8.53M. The position accounts for ﹤0.01% of the portfolio, ranked #1210.
Bank of Montreal first reported a position in TNDM in Q2 2014 and has held it in 38 quarters since. The position peaked at $12M in Q1 2022. 252 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.
- Bank of Montreal held 564,966 shares of Tandem Diabetes Care worth $8.53M as of Q2 2026.
- Bank of Montreal bought 527,531 Tandem Diabetes Care shares in Q2 2026, an estimated $9.21M.
- Tandem Diabetes Care made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #1210 holding.
- Bank of Montreal first reported a position in Tandem Diabetes Care in Q2 2014 and has held it in 38 quarters since.
- Bank of Montreal's Tandem Diabetes Care position peaked at $12M in Q1 2022.
- 252 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.
Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.